Second outbreak of adenovirus reported in N.J.

The second outbreak is believed to be of a milder type than the one responsible for the deaths of 10 children in Wanaque


A second outbreak of adenovirus has been reported at a long-term care facility for medically fragile children in Vorhees, N.J., according to an article on the northjersey.com website. 

The second outbreak is believed to be of a milder type than the one responsible for the deaths of 10 children in Wanaque.

The two facilities are among four in New Jersey that care for children with severe disabilities who depend on ventilators to breathe.

Four children have been diagnosed with the virus at the Voorhees Pediatric Facility. All have mild forms of the illness, and preliminary lab tests have ruled out adenovirus Type 7, which was identified in the Wanaque outbreak.  

Read the article.

 

 



November 7, 2018


Topic Area: Infection Control


Recent Posts

Cleanliness in Hospitals: Clinical Priority and Community Perception

EVS managers and communities value cleanliness for complementary reasons: managers for safety and compliance, communities for trust and comfort.


Dana-Farber Receives $50M Gift for Planned Cancer Hospital

A $50 million grant from the Yawkey Foundation will support construction of Dana-Farber Cancer Institute’s planned 450,000-square-foot cancer hospital.


Clarinda Regional Health Center Reports Data Security Incident

On or around December 15, 2025, Clarinda learned that certain data within its network may have been accessed without authorization.


Gaps in Nurses' Environmental Cleaning Knowledge Grow Amid Rising EVS Pressures

Environmental cleaning is crucial in preventing HAIs, but when the responsibility falls to those outside of EVS teams, problems arise. 


Ground Broken on the Southern Nevada Forensic Facility

Construction on the new secure forensic psychiatric hospital is expected to be completed in 2029.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.